Showing results (371-380 of 483) with videos related to

Sort By:
Pageof 49
Agents and Actions. Supplements|January 1, 1992
Effect of irradiation on the prostaglandin system of human hypernephroma cellsS R Li, I Virgolini, E Wandl, et al.
Revista Espanola De Medicina Nuclear|May 3, 2001
Positive imaging of an inflammatory process at an arteriovenous access site with 111 Indium-labeled plateletsI Neumann, F T Meisl, G Kopriva, et al.
Breast Cancer Research and Treatment|November 10, 2000
99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesionsR Obwegeser, P Berghammer, S Muellauer-Ertl, et al.
Prostaglandins & Other Lipid Mediators|July 8, 1998
Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistanceH Sinzinger, I Neumann, J O'Grady, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1997
PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion techniqueH Sinzinger, I Neumann, J O'Grady, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1992
Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregationR Katzenschlager, K Weiss, W Rogatti, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapyW Klein, V Mitrovic, H Neuss, et al.
Nuclear Medicine Communications|July 15, 1999
111In-labelled platelets for assessment of thrombogenicity of new haemodialysis vascular accessI Neumann, F T Meisl, G Kopriva, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 3, 1998
Alteration of rat cerebral microvascular eicosanoid formation by isradipine, a calcium channel blockerH Sinzinger, T Wasinger, P Böck, et al.
Journal of Clinical Pharmacy and Therapeutics|August 9, 2001
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapyH Sinzinger, G Lupattelli, F Chehne, et al.
Pageof 49